- Filed
- Aug 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Aug 12, 2024 | 229.16M sh |
| Cash And Equivalents | Q3 2024 · Jun 30, 2024 | $789.19K |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $516.96K |
| Current Liabilities | Q3 2024 · Jun 30, 2024 | $1.58M |
| Current Liabilities | Q3 2024 · Sep 30, 2023 | $1.22M |
| Total Liabilities | Q3 2024 · Jun 30, 2024 | $1.62M |
| Total Liabilities | Q3 2024 · Sep 30, 2023 | $1.29M |
| Current Assets | Q3 2024 · Jun 30, 2024 | $1.4M |
| Current Assets | Q3 2024 · Sep 30, 2023 | $1.16M |
| Total Assets | Q3 2024 · Jun 30, 2024 | $1.65M |
| Total Assets | Q3 2024 · Sep 30, 2023 | $1.3M |
| Shares Diluted | Q3 2024 · Jun 30, 2023 | 599.43M sh |
| Shares Diluted | Q3 2024 · Jun 30, 2023 | 599.35M sh |
| Capex | Q3 2024 · Jun 30, 2023 | $6.44K |
| Operating Cash Flow | Q3 2024 · Jun 30, 2023 | −$35.23K |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $49.15K |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $40.53K |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | −$51.38K |
| Eps Diluted | Q3 2024 · Jun 30, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Jun 30, 2023 | $0.00 |
| Sga Expense | Q3 2024 · Jun 30, 2023 | $353.92K |
| Sga Expense | Q3 2024 · Jun 30, 2023 | $970.68K |
| Rd Expense | Q3 2024 · Jun 30, 2023 | $2K |
| Rd Expense | Q3 2024 · Jun 30, 2023 | $25.82K |
| Net Income | Q3 2024 · Jun 30, 2023 | $100.53K |
| Gross Profit restated | Q3 2024 · Jun 30, 2023 | $428.06K |
| Gross Profit restated | Q3 2024 · Jun 30, 2023 | $1.25M |
| Cost Of Revenue restated | Q3 2024 · Jun 30, 2023 | $132.31K |
| Cost Of Revenue restated | Q3 2024 · Jun 30, 2023 | $324.36K |
| Revenue | Q3 2024 · Jun 30, 2023 | $560.37K |
| Revenue | Q3 2024 · Jun 30, 2023 | $1.58M |